A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price ...

The company said a total of 10,335 participants have been enrolled in the late stage trial. Each participant will be ...

RNA-based immunizing agents have enriched the repertoire of technologies used for vaccine development. An analysis of the active clinical trials in early Phase I and Phase I during the year of 2023 ...

Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked by ...

Researchers to examine vaccine development for PEDV and PDCoV, passive barn-cooling technologies to reduce heat stress.

Vaccine development for Porcine Epidemic Diarrhea and Porcine Delta Coronavirus are among new research projects Canadian pork ...

From eradicating smallpox to battling the COVID-19 pandemic, these vaccine pioneers have helped make colossal strides in ...

The government has decided to set up a National Vaccine Fund as a dedicated, professionally managed investment vehicle ...

WASHINGTON -- The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.